ssional standards for the North American fire service and provides a strong voice in the development and implementation of new training programs and equipment.
The IAFF in no way endorses, sponsors, or is otherwise involved in the design, manufacture, sale or distribution of goods and services by the Masimo Corporation. No representation, warranty or condition, express or implied, statutory or otherwise is given or assumed by the IAFF in respect to goods and services designed, manufactured, sold and/or distributed by the Masimo corporation.
Masimo (Nasdaq: MASI) develops innovative monitoring technologies that significantly improve patient care -- helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low-Perfusion pulse oximetry, known as Masimo SET((R)), which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET((R)) Pulse CO-Oximetry(TM), a breakthrough noninvasive blood constituent monitoring platform that can measure many blood constituents that previously required invasive procedures. Masimo Rainbow SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO((R))), methemoglobin (SpMet((R))), and PVI(TM), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), allowing early detection and treatment of potentially life-threatening conditions. Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of Care by Taking Page: 1 2 3 4 5 6 Related medicine news :1
. International study strengthens case for daily calcium pill2
. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference3
. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes4
. LCA Hails International Investigators Studying Lung Cancer5
. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors6
. PRA International Adds Dr. Susan Stansfield as Executive Vice President7
. Medical Services International Maintains Pace in Second Quarter8
. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program9
. International Gateway Insurance Brokers Partners With MEDILINQ10
. Tulane University to receive $14M for international HIV/AIDS program11
. International Database Seeks to Boost Treatment of Altitude Sickness